351 related articles for article (PubMed ID: 35846801)
1. COVID-19 Associated Mucormycosis with Newly Diagnosed Diabetes Mellitus in Young Males - A Tertiary Care Experience.
Kapoor S; Saidha PK; Gupta A; Saini U; Satya S
Int Arch Otorhinolaryngol; 2022 Jul; 26(3):e470-e477. PubMed ID: 35846801
[No Abstract] [Full Text] [Related]
2. A fungal epidemic amidst a viral pandemic: Risk factors for development of COVID-19 associated rhino-orbital-cerebral mucormycosis in India.
Vasanthapuram VH; Gupta R; Adulkar N; Nair AG; Bradoo RA; Hegde R; Singh U; Tadepalli S; Mukherjee B; Kamal S; Alam MS; Rao R; Ananthakrishna S; Backiavathy V; Murthy AK; D'Cunha L; Dudeja G; Joji A; Kiran A; Koka K; Goswami Mukhopadhyay M; Nisar SP; Rao PR; Shinde CA
Orbit; 2023 Feb; 42(1):30-41. PubMed ID: 35192435
[TBL] [Abstract][Full Text] [Related]
3. Rhino-orbito-cerebral mucormycosis and its resurgence during COVID-19 pandemic: A review.
Karkhur S; Soni D; Chauhan K; Sarkar D; Gautam M; Verma S; Nyodu R; Yadav N; Sharma B
Indian J Ophthalmol; 2023 Jan; 71(1):39-56. PubMed ID: 36588206
[TBL] [Abstract][Full Text] [Related]
4. Orbital Mucormycosis: Understanding the Deadly Fungus Sweeping the Globe.
Farooq S; Khan NA; Singh A; Khan A; Sharma P; Meena R; Jakhar A; Kumar M; Kochar A
Cureus; 2023 Jun; 15(6):e41010. PubMed ID: 37519583
[TBL] [Abstract][Full Text] [Related]
5. Uncontrolled diabetes mellitus exacerbated by COVID-19-induced inflammation is the risk factor for COVID-19-associated rhino-orbito-cerebral mucormycosis: A matched pair case-control study.
Karat S; Lobo AC; Satish D; Devaraj R; Manjooran RR; Nithyanandam S
Indian J Ophthalmol; 2022 Aug; 70(8):3096-3101. PubMed ID: 35918980
[TBL] [Abstract][Full Text] [Related]
6. Rhino-Orbital Cerebral Mucormycosis in Non-Diabetic Patients with COVID-19.
Elhamamsy S; Bayer T; Al-Kaffas M; Hatahet S; Grover M; Samdhani S; Nanda A; Gravenstein S
R I Med J (2013); 2021 Oct; 104(8):19-21. PubMed ID: 34582509
[TBL] [Abstract][Full Text] [Related]
7. COVID-19-associated rhino-orbital-cerebral mucormycosis: A systematic review, meta-analysis, and meta-regression analysis.
Bhattacharyya A; Sarma P; Kaur H; Kumar S; Bhattacharyya J; Prajapat M; Prakash A; Sharma S; Reddy DH; Thota P; Bansal S; Gautam BS; Medhi B
Indian J Pharmacol; 2021; 53(6):499-510. PubMed ID: 34975140
[TBL] [Abstract][Full Text] [Related]
8. Surgical & medical management of ROCM (Rhino-orbito-cerebral mucormycosis) epidemic in COVID-19 era and its outcomes - a tertiary care center experience.
Soni K; Das A; Sharma V; Goyal A; Choudhury B; Chugh A; Kumar D; Yadav T; Jain V; Agarwal A; Garg M; Bhatnagar K; Elhence P; Bhatia PK; Garg MK; Misra S
J Mycol Med; 2022 May; 32(2):101238. PubMed ID: 34979299
[TBL] [Abstract][Full Text] [Related]
9. Rhino orbital cerebral mucormycosis in settings of COVID-19 infection: A case series of thirteen patients.
Verma R; Chakraborty R; Keerthiraj DB; Pal US
Natl J Maxillofac Surg; 2023; 14(2):311-316. PubMed ID: 37661985
[TBL] [Abstract][Full Text] [Related]
10. Fatality Chooses Its Path Through the Orbit: A Study of Rhino-Orbito-Cerebral Mucormycosis as a Complication of COVID-19 Infection.
Mehfooz S; Mehrotra N; Usmani T; Raj V
Cureus; 2022 Nov; 14(11):e31822. PubMed ID: 36579288
[TBL] [Abstract][Full Text] [Related]
11. Epidemiology, clinical presentation and management of COVID-19 associated mucormycosis: A single centre experience from Pune, Western India.
Dravid A; Kashiva R; Khan Z; Bande B; Memon D; Kodre A; Mane M; Pawar V; Patil D; Kalyani S; Raut P; Bapte M; Saldanha C; Chandak D; Patil T; Reddy S; Bhayani K; Suresh L; Dillibabu V; Srivastava S; Khandelwal S; More S; Shakeel A; Pawar M; Nande P; Harshe A; Kadam S; Hallikar S; Kamal N; Andrabi D; Bodhale S; Raut A; Chandrashekhar S; Raman C; Mahajan U; Joshi G; Mane D
Mycoses; 2022 May; 65(5):526-540. PubMed ID: 35212032
[TBL] [Abstract][Full Text] [Related]
12. Rhino-orbital mucormycosis following COVID-19 in previously non-diabetic, immunocompetent patients.
Nair AG; Adulkar NG; D'Cunha L; Rao PR; Bradoo RA; Bapaye MM; Kothari A; Dave TV; Shinde CA
Orbit; 2021 Dec; 40(6):499-504. PubMed ID: 34338124
[TBL] [Abstract][Full Text] [Related]
13. COVID-19 associated rhino-orbito-cerebral mucormycosis, risk factors and outcome predictors; a multicentric study.
Rajabi MT; Aghajani A; Rafizadeh SM; Jamshidian Tehrani M; Poursayed Lazarjani SZ; Keshmirshekan MM; Mohammadi A; Akrami A; Parandin MM; Rajabi MB; Hosseini SS; Akbari M
Int Ophthalmol; 2023 Apr; 43(4):1375-1386. PubMed ID: 36209307
[TBL] [Abstract][Full Text] [Related]
14. Study of rhino-orbital-cerebral mucormycosis and its correlates during COVID-19 pandemic in a tertiary eye care institute of central India.
Verma V; Sarkar D; Moharana B; Singh P; Noyadu R; Sharma B
Indian J Ophthalmol; 2023 Dec; 71(12):3669-3676. PubMed ID: 37991302
[TBL] [Abstract][Full Text] [Related]
15. A clinico-pathological study of COVID-19 associated rhino-orbital-cerebral mucormycosis.
Mani S; Thirunavukkarasu A
Indian J Ophthalmol; 2022 Mar; 70(3):1013-1018. PubMed ID: 35225563
[TBL] [Abstract][Full Text] [Related]
16. Hyperglycemia and steroid use increase the risk of rhino-orbito-cerebral mucormycosis regardless of COVID-19 hospitalization: Case-control study, India.
Ponnaiah M; Ganesan S; Bhatnagar T; Thulasingam M; Majella MG; Karuppiah M; Rizwan SA; Alexander A; Sarkar S; Kar SS; Kadhiravan T; Bhatnagar A; S PK; Pillai VM; Nair PP; Dhodapkar R; Ch Toi P; Singh R; Kasthuri N; Kumar GCP; Jaisankar S; Saini V; Kankaria A; Raj A; Goyal A; Sharma V; Khichar S; Soni K; Garg MK; Selvaraj K; B H S; Bhavana K; Bharti B; Singh CM; Chaudhary N; R V; K G; Palaninathan K; Dube S; Saxena RS; Gupta N; Rathinavel A; Priya S; Arulsundareshkumar ; Bellad SA; Kavi A; Harugop AS; Pujary K; Ballala K; Mallya SD; Prasad HM; Ravi D; Balaji NK; Hegde R; Mishra N; Ray S; Karthikeyan S; Ramalingam S; Murali A; Vaidya S; Samadhiya M; Bhojani D; Lakshmanan S; Singh SRB; Pillai N; Deepthi P; Banumathi K; Sumathi V; Ramesh D; Nissar SP; Sheikh KM; Patel MN; Shristava V; Kumar SS; Shantaraman K; Pandian RD; Murhekar M; Aggarwal R
PLoS One; 2022; 17(8):e0272042. PubMed ID: 35939442
[TBL] [Abstract][Full Text] [Related]
17. "MuCovid-21" study: Mucormycosis at an Indian tertiary care centre during the COVID-19 pandemic.
Kumar S; Choudhary R; Pandey VP
J R Coll Physicians Edinb; 2021 Dec; 51(4):352-358. PubMed ID: 34882132
[TBL] [Abstract][Full Text] [Related]
18. Rhino-orbital-cerebral mucormycosis in times of COVID-19: A neurosurgical experience.
Singh H; Dua S; Goel A; Dhar A; Bhadauria V; Garg A; Katyar V; Sharma S; Shukla A
Surg Neurol Int; 2021; 12():538. PubMed ID: 34754588
[TBL] [Abstract][Full Text] [Related]
19. Association of Risk Factors among Nasal and Orbital Mucormycosis in Coronavirus Disease 2019 Infection: A Cross-Sectional Study.
Vidhyadevi R; Saudhamini S; Padmanaban S; Sundar D; Kannappan S; Suryaprabha G
J Curr Ophthalmol; 2022; 34(4):460-464. PubMed ID: 37180537
[TBL] [Abstract][Full Text] [Related]
20. Rhino-Orbito-Cerebral-Mucormycosis During the COVID-19 Second Wave in 2021 - A Preliminary Report from a Single Hospital.
Arora R; Goel R; Khanam S; Kumar S; Shah S; Singh S; Chhabra M; Meher R; Khurana N; Sagar T; Kumar S; Garg S; Kumar J; Saxena S; Pant R
Clin Ophthalmol; 2021; 15():3505-3514. PubMed ID: 34429582
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
